Summary The roles of age and sex and their relationship to other prognostic factors were studied in 117 chronic myeloid leukaemia (CML) and in 256 chronic lymphocytic leukaemia (CLL) patients. Survival in CML was not related either to age at diagnosis or to sex. In contrast, the CLL patients classified into four age strata (<50, 50-59, 60-69, >70 years) had an expected median survival (EMS) of 142, 101, 85 and 33 months respectively (X2 for heterogeneity = 35.59, P <0.0005; X2 for trend = 25.09, P <0.0005). Prognostic power was independent of sex, Rai stages, total tumour mass score (TTM), TTM distribution pattern, anaemia, thrombocytopenia, serum immunoglobulins and response to therapy. The relative survival rate (the ratio of patient's EMS and EMS in age-and sex-matched general population) was 0.40 in CLL patients and 0.13 in CML patients. Relative survival was more reduced in older CLL patients than in younger ones (0.37 vs 0.47, respectively), whereas relative survival was less reduced in older CML patients than in younger ones (0.18 vs 0.12, respectively). The results show that the age is a significant independent prognostic factor in CLL but not in CML. The difference in the effects of age on prognosis in CLL and CML most probably reflects the fundamental differences in their respective pathogeneses.
A number of prognostic factors have been identified to influence survival in chronic leukaemias Binet et al., 1981; Paolino et al., 1984; . Additionally, age and sex may also be important in predicting prognosis. The role of age and sex and their relation to other prognostic factors in chronic leukaemias are, however, controversial. In chronic myeloid leukaemia (CML) Tura et al. (1981) found an adverse influence of age on survival in their 'CML/73' series, but not in their 'Bologna' series. Multivariate analysis done by Silver et al. (1987) indicated that age and sex were important for predicting survival. Dameshek (1967) has postulated that chronic lymphocytic leukaemia (CLL) runs a more malignant course in younger patients. This was, however, challenged by others who found a shorter survival in older patients (Zippin et al., 1973; Boggs et al., 1966; Galton, 1966) . Recently (Catovsky et al., 1989) showed that age and sex were important prognostic factors in CLL. This controversy might originate in the imbalanced distribution of other prognostic factors in the respective series.
This study was done in an attempt to evaluate the prognostic powers of age and sex in chronic leukaemias in unselected patients and to evaluate the relationship of other prognostic factors to age and sex. 
Patients and methods

Patients
Statistical methods
The prognosis was evaluated by measuring survival from diagnosis to death from all causes. Probability of survival was calculated by the product limit actuarial method (Kaplan & Meier, 1958) . Statistical significance of the difference between two or more survival probabilities was tested for heterogeniety and for trend by the longrank test (Peto et al., 1977) . The expected median survival (EMS) of a subset of patients was computed by dividing the median survival of whole CLL group by the relative death rate (O/E) of particular subset. The adjustment for the explanatory variable(s) was performed according to method of Peto et al. (1977) . The continuous quantitative variables such as age, TTM-size, haemoglobin concentration and platelet count were stratified into as few strata as possible to obtain maximal prognostic discrimination.
Because the prognostic power of age was found only in CLL, the relationship between age and other prognostic factors in CLL was studied in details.
Classification of other prognostic factors in CLL Rai classification was used for clinical staging of patients in CLL (Rai et al., 1975 (Jaksic & Vitale, 1981) . Anaemia was defined by the haemoglobin concentration of less than 105 g 1-l for males and less than 95 g -' for females. Thrombocytopenia was defined by platelet count of less than 100 x 109 1' for both sex.
The findings of serum immunoglobulins were classified as follows: (a) normal -the quantity of IgG 700-1,700 mg, IgA 113-562 mg and IgM 55-250 mg without evident spike in electrophoresis; (b) hypoimmunoglobulinemia -any of Ig classes below normal level; (c) hyperimmunoglobulinemiaany of Ig classes above normal level; (d) reduced heterogeneity ('M' spike) in electrophoresis of serum proteins regardless of hypo-or hyperimmunoglobulinemia was classified as finding of monoclonal proteins (Jaksic et al., 1985) . If both hyper and hypo values were present in the same patient, the finding was classified according to the predominant aberration.
Response to therapy was classified as (a) complete response -defined by the decrease of TTM below the diagnostic threshold (score of 2.3) along with the absence of anaemia and/or thromocytopenia; (b) partial response is defined by decrease of TTM for more than 50% of maximal value; (c) non responding patients were those who failed to meet criteria for (a) or (b) (Jaksic & Vitale, 1981 Tura et al. (1981) who found sex to be unrelated to the survival in both of their series. These authors also found no association between age and survival in their 'Bologna' series as distinct from their 'CML/73' series in which age negatively influenced the prognosis. In the later series the patients were treated with splenectomy and polychemotherapy which might explain shorter survival in older age groups, perhaps due to some adverse effect to aggressive therapeutic approach. When their series were pooled together in prognostic power of age was below the level of statistical significance. In contrast to our findings in CML, we found a significant reduction in the absolute survival in older CLL patients. This is in line with findings reported in the literature (Rai et al., 1975; Catovsky et al., 1989; Bernardou, 1973) but in contrast with the view of Dameshek (1967) who postulated more malignant disease course in younger patients. In addition, we found a borderline significance of the prognostic value of sex in CLL patients with the tendency of females to survive better than in males. Similar results were reported in the literature (Zippin et al., 1973; Hansen, 1973; Catovsky et al., 1989) .
A significant difference in the absolute survival among CLL patients of different age could be either (1) related to unequal distribution of CLL characteristics known to influence survival among various age groups or (2) unrelated to the major CLL characteristics. A number of disease characteristics has been identified to influence survival in CLL (Osgood, 1964; Planinc-Peraica et al., 1984) . Thus the shorter survival in older patients could be either due: (a) to a more advanced stage of the disease at diagnosis or (b) to a more accelerated course of the disease with a lesser response to therapy or (c) to some other adverse prognosis factors. To evaluate these possibilities we analysed the prognostic power of age without and with an adjustment performed for unequal distribution of disease stage according to Rai, TTMsize, TTM-distribution pattern, haemoglobin level, platelet count, serum immunoglobulin concentration and response to therapy. After the adjustment performed no significant reduction in the prognostic power of age was observed, indicating the lack of any significant direct relationship between the age and the distribution of the disease characteristics analysed. In other words the age appears independent of other prognostic factors and vice versa, the prognostic factors analysed appeared independent of age. This supports the second alternative postulated i.e. that the observed difference in absolute survival among different age groups is unrelated to CLL characteristics.
Moreover, when the median survival in CLL patients was (Paolino et al., 1984) . This contrasts the causes of death in CML where the vast majority of patients die from a disease transformation to a more malignant condition, most frequently a blastic transformation (Tura et al., 1981) . In comparison to age-and sex-matched general population the reduction of expected survival is more pronounced in younger than in older CML patients. These findings suggest a fundamental difference in biology of chronic leukaemias. CML behaves like a typical neoplasm 'killing' the host after progressing to a more malignant condition. Virtually all patients die from the disease progression which is unrelated to age and sex. In contrast, the CLL 'kills' the patients in a function of their age. Older patients live shorter than younger patients, similar to the situation in general population where older individuals live shorter than younger individuals. Likewise, the females survive better than males in CLL, but this is the case also in general population. Therefore the adverse effect of male sex to survival in CLL is comparable to the effect of sex in general population. Accordingly the results suggest that CLL increases the general risk of dying or somehow 'decrease the viability' of patients. In this respect CLL is more similar to 'premature ageing' than to a typical neoplasm.
